ReWalk Robotics Ltd. (NASDAQ:RWLK)’s share price traded up 11.2% during trading on Thursday . The company traded as high as $7.85 and last traded at $7.23, with a volume of 243,625 shares traded. The stock had previously closed at $6.50.

A number of equities research analysts have issued reports on the stock. Zacks Investment Research raised shares of ReWalk Robotics from a “hold” rating to a “buy” rating and set a $11.00 price target on the stock in a report on Tuesday, May 10th. Jefferies Group reissued a “buy” rating and issued a $16.00 price target on shares of ReWalk Robotics in a report on Sunday, May 8th. Finally, Piper Jaffray Cos. assumed coverage on shares of ReWalk Robotics in a report on Friday, July 15th. They issued an “overweight” rating and a $10.00 price target on the stock. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. ReWalk Robotics currently has an average rating of “Buy” and an average target price of $12.80.

The firm’s 50 day moving average price is $6.69 and its 200 day moving average price is $8.59. The company’s market cap is $88.70 million.

ReWalk Robotics (NASDAQ:RWLK) last issued its earnings results on Thursday, August 4th. The medical device company reported ($0.64) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.53) by $0.11. The company had revenue of $0.82 million for the quarter, compared to analysts’ expectations of $1.95 million. ReWalk Robotics’s revenue for the quarter was up 34.4% on a year-over-year basis. On average, equities research analysts forecast that ReWalk Robotics Ltd. will post ($2.11) earnings per share for the current fiscal year.

In related news, Director Jeff Dykan sold 11,370 shares of the company’s stock in a transaction on Wednesday, June 1st. The shares were sold at an average price of $7.74, for a total transaction of $88,003.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, major shareholder Scp Vitalife Partners Ii Lp sold 20,256 shares of the company’s stock in a transaction on Thursday, May 26th. The stock was sold at an average price of $8.69, for a total transaction of $176,024.64. The disclosure for this sale can be found here.

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. The Company offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.